SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is seeing increased volatility amid discussions around a potential government shutdown resolution, with community members debating whether any deal will trigger a relief rally or if job cut data signals a deeper economic slowdown. Bullish sentiment is growing as dip buyers capitalize on the volatility, while bears remain cautious, eyeing potential market manipulation and a possible bull trap. Traders are closely watching political developments for cues, anticipating a possible gap up depending on weekend news.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders assess market conditions amidst government shutdown concerns and mixed economic data. Community members are debating potential support and resistance levels, with some anticipating a bounce while others foresee further declines. Discussions also revolve around potential rate cuts and their impact on market sentiment.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending due to discussions around its recent pullback from highs and key support levels, with community members assessing potential buying opportunities or further downside. The ETF's performance relative to larger indices like the SPY and QQQ, along with speculation about government reopenings and potential rate cuts, are also driving interest. Traders are actively analyzing technical indicators and options flow to gauge the next directional move for small-cap stocks.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak ($KODK) is trending amid community discussion around potential catalysts and its undervalued status. Traders are pointing to the company's pharma business, battery technology, and balance sheet improvements as reasons for optimism. Some are suggesting a potential short squeeze, drawing parallels to other meme stocks.

Amplify ETF Trust - Amplify Lithium & Battery Technology ETF

The Amplify Lithium & Battery Technology ETF ($BATT) is seeing mixed sentiment as the battery and lithium sector navigates a volatile market, with some traders pointing to potential breakouts while others note fading momentum and key support levels being tested. Discussions revolve around whether $BATT will follow the broader lithium sector, with community members actively debating accumulation levels and potential catalysts. Recent news highlights falling lithium prices, increased electric vehicle adoption and solid-state battery technology.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors discuss the potential for a short squeeze ahead of a key decision from the European Medicines Agency (EMA) regarding its Alzheimer's drug, blarcamesine. Community members are analyzing recent company activity, including conference presentations and personnel moves, for clues about the likelihood of a positive outcome. The debate centers around the potential for significant gains if the drug is approved, versus downside risk if the decision is delayed or negative.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors discuss its recent struggles and potential catalysts for a rebound, including government actions on healthcare and upcoming disclosures from major investors. Community members are closely watching for a potential bottom and debating whether the stock is currently oversold or undervalued given broader market conditions and sector-specific challenges. Discussions also revolve around the impact of political factors, like the government shutdown, on healthcare credits and the potential for related policy changes.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending due to a significant price surge, leading to community discussions about its potential as 'the new Bitcoin' and speculation regarding future price targets. The rally is attributed to increased interest in privacy coins and ZEC's limited supply, with some suggesting a possible supply shock-driven rally. Community members are closely watching short positions and potential liquidations, while others compare ZEC's potential to that of other cryptocurrencies.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors discuss the implications of a rare earth export agreement with China, with community members weighing the balance between short-term relief and long-term U.S. independence in rare earth mineral production. Bullish sentiment points to government support and strategic partnerships, while others express concerns about market volatility and the sustainability of high valuations in the sector. Recent Q3 earnings, including a smaller-than-expected loss and a confirmed prepayment from Apple, have sparked further debate on the company's financial trajectory.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors eagerly anticipate HOPE-3 trial data, crucial for resubmitting their Biologics License Application and potentially securing approval for their DMD treatment; the community buzzes with speculation around data release timelines and the potential for a significant short squeeze upon positive results, particularly with analysts expressing confidence in the treatment's efficacy; some caution that cash preservation is a major concern.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$WRD two weeks ago I thought we&#39;d never see below 10 again and 7 is just around the corner...what a performance

GenZinvestor561

StockTwits For Android 

WeRide Inc. - ADR

 two weeks ago I thought we'd never see below 10 again and 7 is just around the corner...what a performance

Luis

@docdomin I was wrong about 7 as well. There were posts recently saying 7 incoming. I said no way. We&#39;ll have 7 today. Will 6 be up next?

StockTwits Web

 I was wrong about 7 as well. There were posts recently saying 7 incoming. I said no way. We'll have 7 today. Will 6 be up next?

@LubberJML total uncertainty in this stock... we&#39;ve been seeing positive news all month long, yet tanking like a rock on the pond...tbh I don&#39;t know what to expect...

 total uncertainty in this stock... we've been seeing positive news all month long, yet tanking like a rock on the pond...tbh I don't know what to expect...

@docdomin The news has been remarkable longer than the last month but it got better in the last month. This looms over WeRide. The market doe not care or does not agree and it&#39;s happened since the IPO. That one spike was the NVIDIA investment spike but overall, WRD is got trashed and remains that way.

 The news has been remarkable longer than the last month but it got better in the last month. This looms over WeRide. The market doe not care or does not agree and it's happened since the IPO. That one spike was the NVIDIA investment spike but overall, WRD is got trashed and remains that way.

@LubberJML let&#39;s hope for our Chinese friends to drop some yens and hk dollars in the bag someday...

 let's hope for our Chinese friends to drop some yens and hk dollars in the bag someday...